Northern Trust
OCEA

Northern Trust’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Northern Trust’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,775
Closed -$1.45K – 4523
2025
Q1 		$1.45K Hold
26,775
– – ﹤0.01% 4417
2024
Q4 		$14.8K Hold
26,775
– – ﹤0.01% 4400
2024
Q3 		$26.2K Sell
26,775
-51,438
-66% -$55.1K ﹤0.01% 4309
2024
Q2 		$95.4K Sell
78,213
-2,550
-3% -$4.35K ﹤0.01% 4063
2024
Q1 		$306K Sell
80,763
-3,786
-4% -$7.12K ﹤0.01% 3739
2023
Q4 		$55.8K Sell
84,549
-1,087
-1% -$1.49K ﹤0.01% 4220
2023
Q3 		$334K Buy
85,636
+22,796
+36% +$105K ﹤0.01% 3631
2023
Q2 		$378K Buy
+62,840
New +$368K ﹤0.01% 3611

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Northern Trust's OCEA Position: Q2 2025 in Review

Northern Trust sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 26,775 shares — an estimated $1.45K sold.

Northern Trust first reported a position in OCEA in Q2 2023 and held it in 8 quarters. The position peaked at $378K in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Northern Trust reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 26,775 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $1.45K.
  • Northern Trust first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 8 quarters.
  • Northern Trust's Ocean Biomedical, Inc. Common Stock position peaked at $378K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.